Investigation of Wii System Effectiveness on Stroke in Taiwa
- Conditions
- strokeStroke - IschaemicStroke - HaemorrhagicPhysical Medicine / Rehabilitation - Occupational therapy
- Registration Number
- ACTRN12612001129875
- Lead Sponsor
- E-Da Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 20
1) age 20 to 80 years; 2) evidence of a unilateral and first cerebral vascular accident confirmed either by a CT or an MRI head scan (ischemic or hemorrhagic); 3) onset of symptoms for at least six months; 4) ability to follow simple instructions with a Mini-Mental State Examination score greater than 24; 5) ability to produce active shoulder movements on the side of hemiparesis (Fugl-Meyer Assessment Scale greater than or equal to 21); 6) no obvious pain in the affected limb (visual analog scale less than 4); 7) minimal spasticity in the affected limb (Modified Ashworth Scale less than or equal to 2); 8) signed written informed consent before participation.
1) uncontrolled hypertension (greater than 190/110 mm Hg); 2) unstable angina; 3) any history of seizure, except for febrile seizures during childhood; 4) carrying or having an implanted artificial pacemaker; 5) participation in other clinical trials; 6) inability to cooperate with research team due to cognitive or personal factors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The electromyography performance of time-to-peak (TTP) contractions in biceps, triceps, deltoid, flexor carpi radialis and externsor carpi radialis muscles[The baseline, outcome and follow-up measurements were performed prior to treatment (week 0), immediately after treatment (week 4), and four weeks after treatment (week 8).]
- Secondary Outcome Measures
Name Time Method motivation by using the Intrinsic Motivation Inventory[The baseline, outcome and follow-up measurements were performed prior to treatment (week 0), immediately after treatment (week 4), and four weeks after treatment (week 8).]